Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib

Ann Hematol. 2022 Jan;101(1):213-215. doi: 10.1007/s00277-021-04393-3. Epub 2021 Jan 9.

Authors

Fernando Martín-Moro¹, Mónica García-Cosío², Juan Marquet-Palomanes³, María López-Gutiérrez⁴, Héctor Pian-Arias², Francisco Javier López-Jiménez³

Affiliations

¹ Department of Haematology, Ramón y Cajal University Hospital, M-607 km. 9, 100, 28034, Madrid, Spain. fmartinmoro@usal.es.
² Department of Pathology, Ramón y Cajal University Hospital, Madrid, Spain.
³ Department of Haematology, Ramón y Cajal University Hospital, M-607 km. 9, 100, 28034, Madrid, Spain.
⁴ Department of Neurosurgery, Ramón y Cajal University Hospital, Madrid, Spain.

PMID: 33423076
DOI: 10.1007/s00277-021-04393-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives*
Adenine / therapeutic use
Aged
Brain / drug effects
Brain / pathology
Humans
Intracranial Hemorrhages / complications*
Intracranial Hemorrhages / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell / complications*
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Male
Piperidines / therapeutic use*
Protein Kinase Inhibitors / therapeutic use*

Substances

Piperidines
Protein Kinase Inhibitors
ibrutinib
Adenine